Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
1,874.10
-32.95 (-1.73%)
BSENSE

Dec 05

BSE+NSE Vol: 3.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Net Sales
265.15
0.00
Other Operating Income
0.00
0.00
Total Operating income
265.15
0.00
Raw Material Cost
191.52
0.00
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-2.25
0.00
Employee Cost
15.93
0.00
Power Cost
0.00
0.00
Manufacturing Expenses
7.30
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
13.33
0.00
Total Expenditure (Excl Depreciation)
225.83
0.00
Operating Profit (PBDIT) excl Other Income
39.32
0.00
Other Income
0.00
0.00
Operating Profit (PBDIT)
39.32
0.00
Interest
14.26
0.00
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
25.06
0.00
Depreciation
3.31
0.00
Profit Before Tax
21.75
0.00
Tax
5.55
0.00
Provisions and contingencies
0.00
0.00
Profit After Tax
16.20
0.00
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
16.20
0.00
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
16.20
0.00
Equity Capital
4.72
4.72
Face Value
10.0
10.0
Reserves
0.00
0.00
Earnings per share (EPS)
34.32
0.0
Diluted Earnings per share
34.3
0.0
Operating Profit Margin (Excl OI)
14.95%
0.0%
Gross Profit Margin
9.53%
0.0%
PAT Margin
6.16%
0.0%
Public Share Holdings (%)
51.07%
50.84%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 42.60% vs 29.23% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 96.43% vs 32.49% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 60.92% vs 42.01% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 54.66% vs 67.33% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Fredun Pharma With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
265.15
222.53
42.62
19.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
265.15
222.53
42.62
19.15%
Raw Material Cost
191.52
104.03
87.49
84.10%
Purchase of Finished goods
0.00
9.00
-9.00
-100.00%
(Increase) / Decrease In Stocks
-2.25
-0.36
-1.89
-525.00%
Employee Cost
15.93
25.47
-9.54
-37.46%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
7.30
-0.01
7.31
73,100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
13.33
34.87
-21.54
-61.77%
Total Expenditure (Excl Depreciation)
225.83
173.00
52.83
30.54%
Operating Profit (PBDIT) excl Other Income
39.32
49.53
-10.21
-20.61%
Other Income
0.00
1.27
-1.27
-100.00%
Operating Profit (PBDIT)
39.32
50.80
-11.48
-22.60%
Interest
14.26
5.60
8.66
154.64%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
25.06
45.20
-20.14
-44.56%
Depreciation
3.31
9.72
-6.41
-65.95%
Profit Before Tax
21.75
35.48
-13.73
-38.70%
Tax
5.55
9.44
-3.89
-41.21%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
16.20
26.04
-9.84
-37.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
16.20
26.04
-9.84
-37.79%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.01
-0.01
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.20
26.04
-9.84
-37.79%
Equity Capital
4.72
10.38
-5.66
-54.53%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
34.32
25.09
9.23
36.79%
Diluted Earnings per share
34.30
25.09
9.21
36.71%
Operating Profit Margin (Excl OI)
14.95%
22.26%
0.00
-7.31%
Gross Profit Margin
9.53%
20.31%
0.00
-10.78%
PAT Margin
6.16%
11.70%
0.00
-5.54%
Public Share Holdings (%)
51.07%
0.00%
51.07
51.07%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 262.99 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 42.60% vs 29.23% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 16.50 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 96.43% vs 32.49% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.33 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 60.92% vs 42.01% in Sep 2024

Half Yearly - Interest
Interest 14.26 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 54.66% vs 67.33% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.95%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024